Clinical data to date shows efti uniquely positioned to address entire NSCLC patient population through both chemo-free IO-IO and IO-IO-chemo triple combinations
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
With the combination of oral solid, inhalation, dermatology, high potent and oral contraceptive products, this is an important facility of the company
Women of all ages will get round-the-clock access to comprehensive treatment
The data from this study show that MM-II has the potential to provide durable pain relief for our patients
The observations are procedural in nature
The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.
Subscribe To Our Newsletter & Stay Updated
